SmithKline Beecham Argatroban
Executive Summary
Wholesale acquisition cost for anticoagulant is $600 per vial. SmithKline launched the drug Nov. 13 and plans to support medical education programs for the diagnosis and treatment of heparin-induced thrombocytopenia. Argatroban was approved June 30 (1"The Pink Sheet" Oct. 2, In Brief)